Side effects and consequences of antibiotics commonly used in private practice;NEBENWIRKUNGEN UND FOLGEN VON IN DER PRAXIS OFT GEBRAUCHTEN ANTIBIOTIKA

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 13, 1996, Pages 528-534

  Cerny, A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

ADVERSE DRUG REACTION; ALLERGY; ANAPHYLAXIS; BACTERIAL INFECTION; BRONCHOSPASM; CONFERENCE PAPER; DIARRHEA; HEMOLYTIC ANEMIA; HEPATITIS; HUMAN; IATROGENIC DISEASE; NAUSEA; NEUTROPENIA; OTOTOXICITY; PANCREATITIS; PHOTOTOXICITY; RASH; THROMBOCYTOPENIA;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG HYPERSENSITIVITY; FAMILY PRACTICE; HUMANS; LACTAMS;

EID: 0029881405     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Bartlett JG: Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 1994; 18: S265-S272.
2. Catnach, SM, Fairclough PD: Erythromycin and the gut. Gut 1992; 33: 397-401.
3. Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL et al.: Prospective randomized trial of metronidazole versus vancomycin for clostridium difficile associated diarrhea and colitis. Lancet 1983/II: 1043-1046.
4. Wallery T, Milson D: Loperamide-related toxic megacolon on Clostridium difficile colitis. Postgrad Med J 1990; 66: 582-584.
5. McFarland LV, Surawicz CM, Greenbrg RN, Elmer GW, Mover KA et al.: Prevention of β-lactam-associated diarrhea by Saccaromyces boulardii compared with placebo. Am J Gastroenterol 1995; 90: 439-448.
6. Samore MH: Epidemiology of nosocomial Clostridium difficile infection. Compr Ther 1993; 19: 151-156.
7. Van Arsdel PP Jr, Larson EB: Diagnostic tests for patients with suspected allergic diseases. Ann Intern Med 1989; 110: 304-312.
8. Sogn DD, Evans III R, Shepherd GM: Results of the National Institute of Allergy and Infectious Diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivates in hospitalized adults. Arch Intern Med 1992; 152: 1025-1032.
9. Gadde J, Spence M. Wheeler B, Adkinson F Jr: Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993; 270: 2456-2463.
10. Pedersen-Bjergaard J: Cephalotin in the treatment of penicillin-sensitive patients. Acta Allergol 1967; 22: 299-303.
11. Saxon A, Beall GN, Rohr AS, Adelman DC: Immediate hypersensitivity reactions to beta-lactam antiviotics (clinical conference). Ann Intern Med 1987; 107: 204-215.
12. Saxon A: Antibiotic choices for the penicillin-allergic patient. Postgrad Med J 1988; 4: 135-148.
13. Kishiyama JL, Adelman DC: The cross reactivity and immunology of β-lactam antibiotics. Drug Safety 1994; 10: 318-327.
14. Anne S, Reisman RE: Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995; 74: 167-170.
15. Abraham GN, Petz LD, Fudenberg HH: Cephalotin hypersensitivity associated with anti-cephalotin antibodies. Int Arch Allergy 1968; 34: 65-74.
16. Ong R, Sullivan T: Detection and characterization of human IgE to cephalosporin determinants [Abstract]. J Allergy Clin Immunol 1988; 81: 222.
17. Fernandez-Rivas M, Carral CP, Cuevas M, Marti C, Moral A, Senent CJ: Selective allergic reactions zi clavulanic acid. J Allergy Clin Immunol 1995; 95: 748-750.
18. Gorbach SL: Clostridium difficile settles in a nursing home. Hosp Prac 1989; 24: 145-160.
19. Tabaqchali S, Jumaa P: Diagnosis and management of clostridium difficile infection. Br Med J 1995; 310: 1375-1380.
20. Arndt KA, Jick H: Rates of cutaneous reactions ti drugs. A report from the Boston collaborative drug surveillance program. JAMA 1976; 235: 918-923.
21. Bigby M, Jick S, Hershel J, Arndt K: Drug-induced cutaneous reactions. A report from the Boston collaborative drug surveillance program on 15 438 consecutive in patients, 1975 to 1982. JAMA 1986; 356: 3358-3363.
22. Mackowiak PA, LeMaistre CF: Drug fever: a critical appraisal of conventional consepts. Ann Intern Med 1987; 106: 728-733.
23. Pleasants RA, Walker TR, Samuelson WM: Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis. Chest 1994; 106: 1124-1128.
24. Sanders CV, Greenberg MD, Marier RL: Cefamandole and cefoxitin. Ann Intern Med 1985; 103: 70-80.
25. Swabb EA: Review of the clinical pharmacology of the monobactam aztreonam. Am J Med 1985; 78: (Suppl. 2A): 11-18.
26. Bochner BS, Lichtenstein LM: Anaphylaxis. N Engl J Med 1991; 324: 1785-1790.
27. Hicks MJ, Flaitz CM: The role of antibiotics in platelet dysfunction and coagulopathy. Int J Antimicrob Agents 1993; 2: 129-150.
28. Levine LR: Quantitative comparison of adverse reactions to cefaclor vs amoxicillin in a surveillance study. Pediatr Infect Dis 1985; 4: 358-336.
29. Moskovitz BL: Clinical adverse effects during ceftriaxone therapy. Am J Med 1984; 77: 84-88.
30. Stricker BH, Tijssen JG: Serum sickness-like reactions to cefaclor. J Clin Epidemiol 1992; 45: 1177-1184.
31. Hoigné R, Hunziker T: Palpable purpura [Editorial]. Schweiz Med Wochenschr 1992; 122: 1271-1274.
32. Garratty G, Postoway N, Schwellenbach J, McMahill PC: A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion 1991; 31: 176-179.
33. Chambers LA, Donovan LM, Kruskall MS: Ceftazidime-induced hemolysis in a patient with drug-dependent antibodies reactive by immune complex and drug adsorption mechanisms. Am J Clin Pathol 1991; 95: 393-396.
34. Manders SM, Heymann WR: Acute generalized exanthemic pustulosis. Cutis 1994; 54: 194-196.
35. McDonald BJ, Singer JW, Bianco JA: Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients. Ann Pharmacother 1992; 26: 34-35.
36. Brenner S, Wolf R, Ruocco V: Drug-induced pemphigus. I. A survey. Clin Dermatol 1993; 11: 501-505.
37. Blacker KL, Stern RS, Wintroub BU: Cutaneous reactions to drugs. In: Fitzpatrick TB (Hrsg): Dermatology in general medicine. New York: McGraw-Hill, 1993: 1783.
38. Murray KM, Keane WR: Review of drug-induced acute interstitial nephritis. Pharmacotherapy 1992; 12: 462-467.